Cornell Assessment of Pediatric Delirium (CAPD) in Newborn
The Cornell Assessment of Pediatric Delirium (CAPD) is a rapid observational tool used to screen for delirium in critically ill infants, including newborns.
Indications for Use
Used in newborns hospitalized with critical illness to screen for delirium, including hypoactive forms, by brief behavioral observation. Appropriate for term and term‑corrected infants in the NICU and PICU infants when assessing acute changes in awareness or interaction (screen‑positive ≥9) 1 [Level II evidence]. Provides rapid (<2 min) bedside detection with high sensitivity for early identification of brain dysfunction 2 [Level II evidence].
Insights & Cautions
Screening accuracy is unproven in newborns; validation exists only in older PICU infants, where sensitivity is about 91% and specificity 98% (Critical Care Medicine, 2014) 1 [Level II evidence]. A 2023 meta-analysis confirms performance varies across ages and settings 2 [Level II evidence]. Use cautiously in neonates due to limited developmental applicability, high false‑positive risk, and overlap with pain, withdrawal, or encephalopathy.